These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38958425)

  • 21. "I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.
    French R; Holliday Davis M; Aronowitz SV; Crowe M; Abrams M; Edwards G; Lowenstein M
    Addict Sci Clin Pract; 2023 Jun; 18(1):41. PubMed ID: 37355639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis.
    Katzman JG; Greenberg NH; Takeda MY; Moya Balasch M
    J Addict Med; 2019; 13(2):131-138. PubMed ID: 30303890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment.
    Kozak Z; Ciccarone D; Thrul J; Cole TO; Pappas AL; Greenblatt AD; Welsh C; Yoon M; Gann D; Artigiani EE; Wish ED; Belcher AM
    Harm Reduct J; 2023 Feb; 20(1):17. PubMed ID: 36788601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing Opioid Use in Orthopaedic Patients Through Harm Reduction Strategies.
    Worley J
    Orthop Nurs; 2019; 38(2):129-135. PubMed ID: 30865064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction.
    DiPaula BA; Cooke CE; Boyle CJ; Love RC
    J Am Pharm Assoc (2003); 2022; 62(1):241-246. PubMed ID: 34690080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dying alone: the sad irrelevance of naloxone in the context of solitary opiate use.
    Wojcicki JM
    Addiction; 2019 Mar; 114(3):574-575. PubMed ID: 30461114
    [No Abstract]   [Full Text] [Related]  

  • 30. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose.
    Watson DP; Tillson M; Taylor L; Xu H; Ouyang F; Beaudoin FL; O'Donnell D; McGuire AB
    Subst Use Addctn J; 2024 Jul; 45(3):378-389. PubMed ID: 38258819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists.
    Peglow SL; Binswanger IA
    Med Clin North Am; 2018 Jul; 102(4):621-634. PubMed ID: 29933819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities.
    Bennett AS; Elliott L
    Transl Res; 2021 Aug; 234():43-57. PubMed ID: 33684591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American College of Preventive Medicine: Addressing the Opioid Epidemic Through a Prevention Framework.
    Livingston CJ; Berenji M; Titus TM; Caplan LS; Freeman RJ; Sherin KM; Mohammad A; Salisbury-Afshar EM
    Am J Prev Med; 2022 Sep; 63(3):454-465. PubMed ID: 35750550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
    Arendt D
    J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.
    Bach P; Hartung D
    Addict Sci Clin Pract; 2019 Sep; 14(1):30. PubMed ID: 31474225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy.
    Faulkner-Gurstein R
    Soc Sci Med; 2017 May; 180():20-27. PubMed ID: 28315595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Overdose Education and Naloxone Distribution Program of the Baltimore Student Harm Reduction Coalition.
    Lewis DA; Park JN; Vail L; Sine M; Welsh C; Sherman SG
    Am J Public Health; 2016 Jul; 106(7):1243-6. PubMed ID: 27077351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relay: A Peer-Delivered Emergency Department-Based Response to Nonfatal Opioid Overdose.
    Welch AE; Jeffers A; Allen B; Paone D; Kunins HV
    Am J Public Health; 2019 Oct; 109(10):1392-1395. PubMed ID: 31415200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perception of Resource Allocations to Address the Opioid Epidemic.
    Strickland JC; Victor G; Ray B
    J Addict Med; 2022 Sep-Oct 01; 16(5):563-569. PubMed ID: 36201678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.